Skip to content

Arrowhead Research ARWR Deferred Revenue

Deferred Revenue at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$69.2M-14.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$6.12M-65.1%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$856.34M+19.1%
ALN
Alnylam PharmaceuticalsALNY
Revvity logo
RevvityRVTY
Roivant Sciences logo
Roivant SciencesROIV

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's deferred revenue?
Arrowhead Research (ARWR) reported deferred revenue of $108.54M in Q1 2026.
How has Arrowhead Research's deferred revenue changed year-over-year?
Arrowhead Research's deferred revenue increased by 150.9% year-over-year, from $43.27M to $108.54M.
What is the long-term trend for Arrowhead Research's deferred revenue?
Over 5 years (2020 to 2025), Arrowhead Research's deferred revenue has grown at a -34.1% compound annual growth rate (CAGR), from $19.29M to $2.4M.
What does deferred revenue mean?
Cash received from customers for work that has not yet been completed.
How do you interpret deferred revenue?
An increase indicates strong future revenue potential from existing contracts, while a decrease suggests revenue recognition is outpacing new bookings.
How does deferred revenue compare across companies?
Highly relevant for biotech companies with R&D partnerships and milestone-based revenue models.